000181600 001__ 181600
000181600 005__ 20240229145650.0
000181600 0247_ $$2doi$$a10.1007/s10654-022-00900-6
000181600 0247_ $$2pmid$$apmid:36063305
000181600 0247_ $$2ISSN$$a0393-2990
000181600 0247_ $$2ISSN$$a1573-7284
000181600 0247_ $$2altmetric$$aaltmetric:135402503
000181600 037__ $$aDKFZ-2022-02101
000181600 041__ $$aEnglish
000181600 082__ $$a610
000181600 1001_ $$00000-0001-9635-0416$$aMayén, Ana-Lucia$$b0
000181600 245__ $$aA longitudinal evaluation of alcohol intake throughout adulthood and colorectal cancer risk.
000181600 260__ $$aDordrecht [u.a.]$$bSpringer Science + Business Media B.V.$$c2022
000181600 3367_ $$2DRIVER$$aarticle
000181600 3367_ $$2DataCite$$aOutput Types/Journal article
000181600 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1665147704_4150
000181600 3367_ $$2BibTeX$$aARTICLE
000181600 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000181600 3367_ $$00$$2EndNote$$aJournal Article
000181600 500__ $$a2022 Sep;37(9):915-929
000181600 520__ $$aAlcohol intake is an established risk factor for colorectal cancer (CRC); however, there is limited knowledge on whether changing alcohol drinking habits during adulthood modifies CRC risk.Leveraging longitudinal exposure assessments on alcohol intake at different ages, we examined the relationship between change in alcohol intake and subsequent CRC risk.Within the European Prospective Investigation into Cancer and Nutrition, changes in alcohol intake comparing follow-up with baseline assessments were investigated in relation to CRC risk. The analysis included 191,180, participants and 1530 incident CRC cases, with exclusion of the first three years of follow-up to minimize reverse causation. Trajectory profiles of alcohol intake, assessed at ages 20, 30, 40, 50 years, at baseline and during follow-up, were estimated using latent class mixed models and related to CRC risk, including 407,605 participants and 5,008 incident CRC cases.Mean age at baseline was 50.2 years and the follow-up assessment occurred on average 7.1 years later. Compared to stable intake, a 12 g/day increase in alcohol intake during follow-up was positively associated with CRC risk (HR = 1.15, 95%CI 1.04, 1.25), while a 12 g/day reduction was inversely associated with CRC risk (HR = 0.86, 95%CI 0.78, 0.95). Trajectory analysis showed that compared to low alcohol intake, men who increased their alcohol intake from early- to mid- and late-adulthood by up to 30 g/day on average had significantly increased CRC risk (HR = 1.24; 95%CI 1.08, 1.42), while no associations were observed in women. Results were consistent by anatomical subsite.Increasing alcohol intake during mid-to-late adulthood raised CRC risk, while reduction lowered risk.
000181600 536__ $$0G:(DE-HGF)POF4-313$$a313 - Krebsrisikofaktoren und Prävention (POF4-313)$$cPOF4-313$$fPOF IV$$x0
000181600 588__ $$aDataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
000181600 650_7 $$2Other$$aAlcohol change
000181600 650_7 $$2Other$$aAlcohol intake
000181600 650_7 $$2Other$$aColorectal cancer
000181600 650_7 $$2Other$$aLatent class mixed models
000181600 650_7 $$2Other$$aLongitudinal exposure
000181600 650_7 $$2Other$$aTrajectory profile analysis
000181600 7001_ $$aViallon, Vivian$$b1
000181600 7001_ $$aBotteri, Edoardo$$b2
000181600 7001_ $$aProust-Lima, Cecile$$b3
000181600 7001_ $$aBagnardi, Vincenzo$$b4
000181600 7001_ $$aBatista, Veronica$$b5
000181600 7001_ $$aCross, Amanda J$$b6
000181600 7001_ $$aLaouali, Nasser$$b7
000181600 7001_ $$aMacDonald, Conor J$$b8
000181600 7001_ $$aSeveri, Gianluca$$b9
000181600 7001_ $$0P:(DE-He78)fb68a9386399d72d84f7f34cfc6048b4$$aKatzke, Verena$$b10$$udkfz
000181600 7001_ $$aBergmann, Manuela M$$b11
000181600 7001_ $$aSchulze, Mattias B$$b12
000181600 7001_ $$aTjønneland, Anne$$b13
000181600 7001_ $$aEriksen, Anne Kirstine$$b14
000181600 7001_ $$aDahm, Christina C$$b15
000181600 7001_ $$aAntoniussen, Christian S$$b16
000181600 7001_ $$aJakszyn, Paula$$b17
000181600 7001_ $$aSánchez, Maria-Jose$$b18
000181600 7001_ $$aAmiano, Pilar$$b19
000181600 7001_ $$aColorado-Yohar, Sandra M$$b20
000181600 7001_ $$aArdanaz, Eva$$b21
000181600 7001_ $$aTravis, Ruth$$b22
000181600 7001_ $$aPalli, Domenico$$b23
000181600 7001_ $$aSabina, Sieri$$b24
000181600 7001_ $$aTumino, Rosario$$b25
000181600 7001_ $$aRicceri, Fulvio$$b26
000181600 7001_ $$aPanico, Salvatore$$b27
000181600 7001_ $$aBueno-de-Mesquita, Bas$$b28
000181600 7001_ $$aDerksen, Jeroen W G$$b29
000181600 7001_ $$aSonestedt, Emily$$b30
000181600 7001_ $$aWinkvist, Anna$$b31
000181600 7001_ $$aHarlid, Sophia$$b32
000181600 7001_ $$aBraaten, Tonje$$b33
000181600 7001_ $$aGram, Inger Torhild$$b34
000181600 7001_ $$aLukic, Marko$$b35
000181600 7001_ $$aJenab, Mazda$$b36
000181600 7001_ $$aRiboli, Elio$$b37
000181600 7001_ $$aFreisling, Heinz$$b38
000181600 7001_ $$aWeiderpass, Elisabete$$b39
000181600 7001_ $$aGunter, Marc J$$b40
000181600 7001_ $$00000-0001-9358-7338$$aFerrari, Pietro$$b41
000181600 773__ $$0PERI:(DE-600)2004992-4$$a10.1007/s10654-022-00900-6$$n9$$p915-929$$tEuropean journal of epidemiology$$v37$$x0393-2990$$y2022
000181600 909CO $$ooai:inrepo02.dkfz.de:181600$$pVDB
000181600 9101_ $$0I:(DE-588b)2036810-0$$6P:(DE-He78)fb68a9386399d72d84f7f34cfc6048b4$$aDeutsches Krebsforschungszentrum$$b10$$kDKFZ
000181600 9131_ $$0G:(DE-HGF)POF4-313$$1G:(DE-HGF)POF4-310$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lKrebsforschung$$vKrebsrisikofaktoren und Prävention$$x0
000181600 9141_ $$y2022
000181600 915__ $$0StatID:(DE-HGF)3002$$2StatID$$aDEAL Springer$$d2021-01-28$$wger
000181600 915__ $$0StatID:(DE-HGF)0160$$2StatID$$aDBCoverage$$bEssential Science Indicators$$d2021-01-28
000181600 915__ $$0StatID:(DE-HGF)1190$$2StatID$$aDBCoverage$$bBiological Abstracts$$d2021-01-28
000181600 915__ $$0StatID:(DE-HGF)0113$$2StatID$$aWoS$$bScience Citation Index Expanded$$d2021-01-28
000181600 915__ $$0StatID:(DE-HGF)0430$$2StatID$$aNational-Konsortium$$d2022-11-17$$wger
000181600 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2022-11-17
000181600 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2022-11-17
000181600 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2022-11-17
000181600 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2022-11-17
000181600 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2022-11-17
000181600 915__ $$0StatID:(DE-HGF)1110$$2StatID$$aDBCoverage$$bCurrent Contents - Clinical Medicine$$d2022-11-17
000181600 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences$$d2022-11-17
000181600 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bEUR J EPIDEMIOL : 2021$$d2022-11-17
000181600 915__ $$0StatID:(DE-HGF)9910$$2StatID$$aIF >= 10$$bEUR J EPIDEMIOL : 2021$$d2022-11-17
000181600 9201_ $$0I:(DE-He78)C020-20160331$$kC020$$lC020 Epidemiologie von Krebs$$x0
000181600 980__ $$ajournal
000181600 980__ $$aVDB
000181600 980__ $$aI:(DE-He78)C020-20160331
000181600 980__ $$aUNRESTRICTED